The Kirby Institute
Level 5, Wallace Wurth Building, UNSW
Sydney NSW 2052
Evan received his BSc (Hons) from the University of Manitoba in Winnipeg, Canada between 2009 and 2013. Research for his Honours was done in the field of animal cell technology. Evan recieved a CanHepC PhD scholarship and began his PhD in 2014 at the University of New South Wales under CanHepC mentor Prof. Jason Grebely, as wel as under the cosupervision of Dr. Tanya Applegate, Dr. Behzad Hajarizadeh, Prof. Andrew Lloyd, and Prof. Greg Dore. His research was focused on the transmission and treatment of HCV infection in people who inject drugs.
Since completing his PhD in 2017, Evan has worked as a postdoctoral researcher at the Kirby Institute and now holds a CanHepC postdoctoral fellowship under the mentorship of Prof. Jason Grebely. His most recent research is focused on the assessing HCV treatment outcomes in people who inject drugs, including reinfection and quality of life, and investigating the dynamics of treatment scale up and HCV epidemiology in prisons.
